Market Research Logo

US Market Overview for Laparoscopic Devices 2017 - MedView

US Market Overview for Laparoscopic Devices 2017 - MedView

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
Laparoscopy has been practiced for almost a century. It is a minimally invasive surgical technique in which operations in the abdominal or pelvic cavities are performed through small incisions that are usually between 5 mm to 15 mm. Laparoscopic access devices, or trocars, facilitate the insertion of various instruments into the patients abdomen, allowing the surgeon to carry out the procedure. Laparoscopes are inserted through a port of access, often at the site of the umbilicus or subxyphoid, and are equipped to illuminate and display the peritoneal cavity to allow the surgical team to perform abdominal and pelvic surgeries. Depending on the type of procedure, the number of incisions will vary; the average is three to four incisions per procedure. These sites provide entrance for other laparoscopic devices to enter the body cavity. Various hand instruments such as scissors, dissectors and graspers are used for manipulating and maneuvering organs and tissue. Alternative devices using direct energy and ultrasonic energy may be used for grasping, cutting and coagulating the tissue.

Insufflators are used for pumping carbon dioxide in to the abdominal cavity to create a pneumoperitoneum in preparation for laparoscopic surgery. The pumping of the gas creates sufficient space within the abdominal cavity for insertion and manipulation of laparoscopic devices with an adequate optical field. Suction-irrigation pumps are used to regulate fluids during the operation. Upon completion of the surgery, closure devices are used to close vessels and other internal wounds to enhance hemostasis. Some procedures such as tubal ligation and certain bariatric procedures can involve the implantation of specialized devices designed specifically for an intended procedure. Specialized laparoscopic devices such as gastric bands and female sterilization implants are analyzed separately.

Clinical data clearly shows that while laparoscopic surgery is often more expensive to perform compared to open surgery, these heightened costs are outweighed by substantial benefits to the patient, including a reduced hospital stay, less scarring and a significantly shorter recovery period.

The full report suite on the U.S. market for laparoscopic devices includes laparoscopes, access devices, hand instruments, insufflation devices, suction-irrigation devices, direct energy devices, ultrasonic energy devices, hand-assisted devices, closure devices, gastric bands, powered morcellators, and female sterilization devices.


EXECUTIVE SUMMARY
U.S. LAPAROSCOPIC DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURES COVERED
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 INTRODUCTION
2.1.1 Gynecological Conditions
2.1.1.1 Gynecological Cancers
2.1.1.2 Uterine Fibroids
2.1.1.3 Endometriosis
2.1.1.4 Menorrhagia
2.1.1.5 Pelvic Prolapse
2.1.1.6 Ectopic Pregnancy
2.1.1.7 Hysterectomy
2.1.2 Digestive Tract Conditions
2.1.2.1 Stomach Cancer
2.1.2.2 Hernia
2.1.2.3 Gallbladder Attack
2.1.2.4 Obesity
2.1.3 Colorectal Conditions
2.1.3.1 Colorectal Cancer
2.1.3.2 Inflammatory Bowel Disease
2.1.3.3 Diverticulitis
U.S. LAPAROSCOPIC DEVICE MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET OVERVIEW
3.3 TREND ANALYSIS BY SEGMENT
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE MARKET SHARE ANALYSIS
3.6 MARKET TRENDS
3.7 EMERGING TECHNOLOGIES
3.8 COMPANY PROFILES
3.8.1 Applied Medical
3.8.2 B. Braun Melsungen AG
3.8.3 Ethicon
3.8.4 Karl Storz
3.8.5 Medtronic
3.8.6 Olympus
3.8.7 Richard Wolf
3.8.8 Stryker
3.9 SWOT ANALYSIS
3.9.1 Ethicon
3.9.2 Karl Storz
3.9.3 Medtronic
3.9.4 Olympus
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
5.1 INTRODUCTION
5.2 PRESS RELEASES
5.2.1 B. Braun Aesculap
5.2.1.1 Change in the B. Braun Management Board and the Aesculap Management Board
5.2.1.2 B. Braun Launches Easypump® Home Infusion Therapy App For Healthcare Professionals and Patients
5.2.1.3 B. Braun continues its sales and earnings growth
5.2.1.4 Change in the B. Braun Management Board
5.2.1.5 B. Braun Launches Prontosan® Wound Gel X
5.2.1.6 B. Braun's growth trend continues
5.2.2 Ethicon
5.2.2.1 ETHICON ANNOUNCES 510(k) CLEARANCE FOR ECHELON CIRCULAR™ POWERED STAPLER
5.2.2.2 ETHICON ANNOUNCES COMPLETION OF ACQUISITION OF TORAX MEDICAL, INC.
5.2.2.3 ETHICON AND DEPUY SYNTHES INTRODUCE CUSTOMIZED WOUND CLOSURE KITS AIMING TO IMPROVE EFFICIENCIES AND PATIENT OUTCOMES IN ORTHOPAEDIC SURGERY
5.2.2.4 New Data Shows ECHELON FLEX™ Powered Staplers Associated with Clinical And Economic Benefits Compared to Medtronic ENDO GIA™ Manual Staplers
5.2.2.5 ETHICON LAUNCHES ENSEAL® X1 LARGE JAW TISSUE SEALER, ESTABLISHING NEXT GENERATION OF ADVANCED BIPOLAR DEVICES
5.2.2.6 New England Journal of Medicine Publishes Five Year Data from Ethicon-Funded STAMPEDE Study
5.2.2.7 THE ECHELON FLEX™ GST SYSTEM WILL NOW FEATURE A 45MM ENDOCUTTER WITH EXCLUSIVE GRIPPING SURFACE TECHNOLOGY RELOADS
5.2.2.8 Ethicon Announces Acquisition of Megadyne Medical Products, Inc.
5.2.2.9 ETHICON LAUNCHES HARMONIC® HD 1000i SHEARS TO ADDRESS CHALLENGES IN COMPLEX SURGICAL PROCEDURES
5.2.2.10 ETHICON WIDENS COMPREHENSIVE ADVANCED ENERGY PORTFOLIO WITH ADDITION OF ENSEAL® X1 LARGE JAW TISSUE SEALER
5.2.2.11 ETHICON ANNOUNCES STRATEGIC COLLABORATION WITH TOUCH SURGERY TO EVOLVE MEDICAL EDUCATION
5.2.2.12 ETHICON ESTABLISHES UNMATCHED KNOTLESS SUTURE PORTFOLIO WITH LAUNCH OF STRATAFIX™ SPIRAL PLUS DEVICES
5.2.2.13 ETHICON RECEIVES U.S. FOOD AND DRUG ADMINISTRATION 510(K) CLEARANCE FOR HARMONIC® HD 1000i SHEARS
5.2.2.14 ETHICON’S HARMONIC ACE®+7 SHEARS PROVIDE RELIABLE SEALING, REQUIRE FEWER SURGICAL DEVICES IN COLECTOMY AND HYSTERECTOMY
5.2.2.15 Ethicon Announces Completion Of Acquisition Of NeuWave Medical, Inc.
5.2.3 Karl Storz
5.2.3.1 KARL STORZ video laryngoscope awarded the German Innovation Award 2017
5.2.3.2 KARL STORZ is partner of an EU-funded project
5.2.3.3 KARL STORZ establishes new production building in Estonia
5.2.3.4 KARL STORZ Installs Advanced Blue Light Cystoscopy System at Naval Medical Center San Diego
5.2.3.5 Sybill Storz Honored as Pioneer in Endoscopy
5.2.4 Medtronic
5.2.4.1 Medtronic Signs Definitive Agreement to Divest a Portion of Its Patient Monitoring & Recovery Division to Cardinal Health for $6.1 Billion
5.2.4.2 Medtronic Announces Worldwide Voluntary Field Corrective Action For Newport(TM) HT70 and Newport(TM) HT70 Plus Ventilators
5.2.4.3 Medtronic Introduces Signia(TM) Stapling System, Innovative Surgical Stapler for Minimally Invasive Surgery
5.2.4.4 Medtronic Receives Expanded Indication From FDA for Pillcam(TM) Colon 2 Capsule
5.2.5 Olympus
5.2.5.1 Sevenfold prizewinner: Olympus receives six iF Design Awards and one Red Dot Award. Medical technology and microscopy products particularly successful.
5.2.5.2 Olympus ENDOCUFF Now FDA 510(k)-Cleared to Claim Improvement in Adenoma Detection Rate during Colonoscopy
5.2.5.3 Olympus VISERA 4K UHD Receives “Excellence in Surgical Products Awards,” Minimally Invasive Surgical Product Category
5.2.5.4 Olympus Showcases Advancements and Milestones in EndoTherapy at ACG
5.2.5.5 Double your energy, enhance safety and speed: Olympus THUNDERBEAT Type S is incorporating all-new Intelligent Tissue Monitoring for superior dissection with optimal temperature control
5.2.6 Richard Wolf
5.2.6.1 The new definition of sharp
5.2.6.2 Richard Wolf establishes a new subsidiary company RIWOspine
5.2.6.3 New flexibility in endoscopic imaging
5.2.6.4 The new “blue” Standard for Photodynamic Diagnostics (PDD)
5.2.7 Stryker
5.2.7.1 Stryker reports 2016 results and 2017 outlook
5.2.7.2 Stryker provides 2016 preliminary net sales results
5.2.7.3 Stryker announces multi-year partnership with Indo UK Institute of Health to deliver affordable orthopaedic care in India
5.2.7.4 Stryker acquires Stanmore Implants Worldwide Limited
5.2.7.5 Stryker completes acquisition of Physio-Control International, Inc.
5.2.7.6 Stryker completes acquisition of Sage Products, LLC
5.2.7.7 Stryker Announces Definitive Agreement to Acquire Physio-Control International, Inc. for $1.28 Billion
5.2.7.8 Stryker Announces Definitive Agreement to Acquire Sage Products, LLC from Madison Dearborn Partners for $2.775 Billion
5.2.7.9 Stryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer
List of Charts
Chart 1 1: Laparoscopic Device Market by Segment, U.S., 2013 – 2023
Chart 1 2: Laparoscopic Device Market Overview, U.S., 2016 & 2023
Chart 3 1: Laparoscopic Device Market by Segment, U.S., 2013 – 2023
Chart 3 2: Laparoscopic Device Market Breakdown, U.S., 2016
Chart 3 3: Laparoscopic Device Market Breakdown, U.S., 2023
Chart 3 4: Growth Rates by Segment, Laparoscopic Device Market, U.S., 2013 – 2023
Chart 3 5: Leading Competitors, Laparoscopic Device Market, U.S., 2016
List oFigures
Figure 1 1: Laparoscopic Device Market Share Ranking by Segment, U.S., 2016 (1 of 3)
Figure 1 2: Laparoscopic Device Market Share Ranking by Segment, U.S., 2016 (2 of 3)
Figure 1 3: Laparoscopic Device Market Share Ranking by Segment, U.S., 2016 (3 of 3)
Figure 1 4: Companies Researched in this Report, U.S., 2016
Figure 1 5: Factors Impacting the Laparoscopic Device Market by Segment, U.S. (1 of 3)
Figure 1 6: Factors Impacting the Laparoscopic Device Market by Segment, U.S. (2 of 3)
Figure 1 7: Factors Impacting the Laparoscopic Device Market by Segment, U.S. (3 of 3)
Figure 1 8: Recent Events in the Laparoscopic Device Market, U.S., 2014 – 2017
Figure 1 9: Laparoscopic Device Procedures Covered, U.S., 2016 (1 of 2)
Figure 1 10: Laparoscopic Device Procedures Covered, U.S., 2016 (2 of 2)
Figure 1 11: Procedure Codes Investigated, U.S., 2016
Figure 1 12: Laparoscopic Device Markets Covered, U.S., 2016 (1 of 2)
Figure 1 13: Laparoscopic Device Markets Covered, U.S., 2016 (2 of 2)
Figure 1 14: Key Report Updates
Figure 1 15: Version History
Figure 3 1: Laparoscopic Device Market by Segment, U.S., 2013 – 2023 (US$M) (1 of 2)
Figure 3 2: Laparoscopic Device Market by Segment, U.S., 2013 – 2023 (US$M) (2 of 2)
Figure 3 3: Laparoscopic Device Market Growth by Segment, U.S., 2013 – 2023 (1 of 2)
Figure 3 4: Laparoscopic Device Market Growth by Segment, U.S., 2013 – 2023 (2 of 2)
Figure 3 5: Drivers and Limiters, Laparoscopic Device Market, U.S., 2016
Figure 3 6: Leading Competitors, Laparoscopic Device Market, U.S., 2016 (1 of 2)
Figure 3 7: Leading Competitors, Laparoscopic Device Market, U.S., 2016 (2 of 2)
Figure 3 8: SWOT Analysis, Karl Storz, 2017
Figure 3 9: SWOT Analysis, Medtronic, 2017
Figure 3 10: SWOT Analysis, Olympus, 2017
Figure 5 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report